Syros Pharmaceuticals, Inc.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Sep'24 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Sep 2024 is 0.00% vs 0.00% in Jun 2024",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Sep 2024 is 72.53% vs -529.73% in Jun 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Jun'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-25.90",
          "val2": "-27.10",
          "chgp": "4.43%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.30",
          "val2": "1.40",
          "chgp": "-7.14%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "20.30",
          "val2": "4.40",
          "chgp": "361.36%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-6.40",
          "val2": "-23.30",
          "chgp": "72.53%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'23",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2023 is -33.56% vs -36.60% in Dec 2022",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2023 is -73.81% vs -9.35% in Dec 2022",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'23",
        "Dec'22",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "9.90",
          "val2": "14.90",
          "chgp": "-33.56%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-124.20",
          "val2": "-123.40",
          "chgp": "-0.65%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "5.10",
          "val2": "4.10",
          "chgp": "24.39%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-39.80",
          "val2": "33.70",
          "chgp": "-218.10%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-164.60",
          "val2": "-94.70",
          "chgp": "-73.81%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-12,731.40%",
          "val2": "-8,492.10%",
          "chgp": "-423.93%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Sep'24 - QoQ

Sep'24

Jun'24

Change(%)

Net Sales

0.00

0.00

Operating Profit (PBDIT) excl Other Income

-25.90

-27.10

4.43%

Interest

1.30

1.40

-7.14%

Exceptional Items

20.30

4.40

361.36%

Consolidate Net Profit

-6.40

-23.30

72.53%

Operating Profit Margin (Excl OI)

0.00%

0.00%

NA

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Sep 2024 is 0.00% vs 0.00% in Jun 2024

Consolidated Net Profit

QoQ Growth in quarter ended Sep 2024 is 72.53% vs -529.73% in Jun 2024

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'23

Dec'23

Dec'22

Change(%)

Net Sales

9.90

14.90

-33.56%

Operating Profit (PBDIT) excl Other Income

-124.20

-123.40

-0.65%

Interest

5.10

4.10

24.39%

Exceptional Items

-39.80

33.70

-218.10%

Consolidate Net Profit

-164.60

-94.70

-73.81%

Operating Profit Margin (Excl OI)

-12,731.40%

-8,492.10%

-423.93%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2023 is -33.56% vs -36.60% in Dec 2022

Consolidated Net Profit

YoY Growth in year ended Dec 2023 is -73.81% vs -9.35% in Dec 2022

All Annual Results